Who we help

Adults who have exhausted conventional options

For the MS, Parkinson's, diabetes or arthritis patient for whom standard medicine has reached its limit.

For Adults who have exhausted conventional options
A calm, private EU clinical setting.

Do not replace established treatment with an investigational product on the basis of marketing. Compare product-specific evidence, regulatory status, written costs and follow-up with an independent clinician.

How to evaluate Bulgaria for your situation

  • Ask how the proposal relates to your existing care and who remains clinically responsible.
  • Treatment is delivered inside the EU. Compare written quotations directly — we publish source observations rather than a headline saving.
  • Request the visit, monitoring and follow-up schedule in writing before travel.
  • Evaluate any supportive-care or climate claim independently from the cell product.

Compare like with like

Country ranges may describe different products, doses, visits and inclusions. Request itemised current quotations, record each source and retrieval date, and verify the regulatory status of the exact proposal before comparing totals.

Safety & practicalities note

EUBulgaria is an EU member state, but that does not verify a specific provider, product or treatment.
Check current government travel advice, insurance, accessibility and emergency arrangements for your own dates.
Entry requirements vary by nationality and trip length. Check current official Bulgarian guidance before booking.
Request a current written quotation with inclusions, exclusions, cancellation and refund terms.

This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.

Your situation, specifically

These conditions are the most relevant for your situation:

An online guide cannot determine candidacy. Ask an independent qualified clinician to review the proposed product, evidence, risks and alternatives before you consent or pay.

Educational information. Outcomes vary by patient; consult a qualified physician.

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information